CS
DTIL icon

Candriam SCA’s Precision BioSciences DTIL Stock Holding History

Candriam SCA’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,105
Closed -$4.68M – 816
2021
Q4 		$4.68M Hold
21,105
– – 0.03% 371
2021
Q3 		$7.31M Hold
21,105
– – 0.05% 326
2021
Q2 		$7.93M Buy
+21,105
New +$6.34M 0.05% 321

Other funds holding DTIL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Candriam SCA's DTIL Position: Q1 2022 in Review

Candriam SCA sold out of Precision BioSciences (DTIL) in Q1 2022, closing a stake of 21,105 shares — an estimated $4.68M sold.

Candriam SCA first reported a position in DTIL in Q2 2021 and held it in 3 quarters. The position peaked at $7.93M in Q2 2021. 152 funds tracked by Wall St. Rank hold DTIL as of Q1 2022.

  • Candriam SCA reported no remaining Precision BioSciences position as of Q1 2022 after selling out during the quarter.
  • Candriam SCA sold 21,105 Precision BioSciences shares in Q1 2022, an estimated $4.68M.
  • Candriam SCA first reported a position in Precision BioSciences in Q2 2021 and held it in 3 quarters.
  • Candriam SCA's Precision BioSciences position peaked at $7.93M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2022.

Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.